BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37681334)

  • 21. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of transcription factor co-regulators that drive prostate cancer progression.
    Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ
    Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.
    Zhou Y; Xiao D; Jiang X; Nie C
    J Transl Med; 2023 Jan; 21(1):28. PubMed ID: 36647156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
    Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
    Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
    BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.
    Bindukumar B; Schwartz SA; Nair MP; Aalinkeel R; Kawinski E; Chadha KC
    Neoplasia; 2005 Mar; 7(3):241-52. PubMed ID: 15799824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAIAP2L2 facilitates the malignancy of prostate cancer (PCa) via VEGF and apoptosis signaling pathways.
    Song Y; Zhuang G; Li J; Zhang M
    Genes Genomics; 2021 Apr; 43(4):421-432. PubMed ID: 33646530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing.
    Zhao S; Ji W; Shen Y; Fan Y; Huang H; Huang J; Lai G; Yuan K; Cheng C
    BMC Cancer; 2022 Dec; 22(1):1274. PubMed ID: 36474171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
    Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
    Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer.
    Yang M; Liu H; Qiu GP; Gao F
    Med Oncol; 2021 Nov; 39(1):8. PubMed ID: 34761338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
    Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.
    Pan XW; Gan SS; Ye JQ; Fan YH; Hong Υ; Chu CM; Gao Y; Li L; Liu X; Chen L; Huang Y; Xu H; Ren JZ; Yin L; Qu FJ; Huang H; Cui XG; Xu DF
    Int J Oncol; 2016 Nov; 49(5):1963-1972. PubMed ID: 27667360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
    Zhang G; He X; Ren C; Lin J; Wang Q
    J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
    Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
    BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
    Lin ZY; Chen G; Zhang YQ; He HC; Liang YX; Ye JH; Liang YK; Mo RJ; Lu JM; Zhuo YJ; Zheng Y; Jiang FN; Han ZD; Wu SL; Zhong WD; Wu CL
    Mol Cancer; 2017 Feb; 16(1):48. PubMed ID: 28241827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.